Medipal Holdings Corp - ESG Rating & Company Profile powered by AI
The ESG rating covers 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Sustainable Cities & Communities' and 'Life below Water'. Scroll down to the end of this page for potential risks for Medipal Holdings Corp based on industry, location and marketcap. This dashboard contains a Q&A section for Medipal Holdings Corp.
Medipal Holdings Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 0.0, social score of 2.3 and governance score of 1.3.
1.2
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
1755 | Trimurthi Ltd | 1.3 | Low |
1779 | Medipal Holdings Corp | 1.2 | Low |
1779 | Cell Biotech Co Ltd | 1.2 | Low |
1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Medipal Holdings Corp have an accelerator or VC vehicle to help deliver innovation?
Does Medipal Holdings Corp disclose current and historical energy intensity?
Does Medipal Holdings Corp report the average age of the workforce?
Does Medipal Holdings Corp reference operational or capital allocation in relation to climate change?
Does Medipal Holdings Corp disclose its ethnicity pay gap?
Does Medipal Holdings Corp disclose cybersecurity risks?
Does Medipal Holdings Corp offer flexible work?
Does Medipal Holdings Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Medipal Holdings Corp disclose the number of employees in R&D functions?
Does Medipal Holdings Corp conduct supply chain audits?
Does Medipal Holdings Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Medipal Holdings Corp conduct 360 degree staff reviews?
Does Medipal Holdings Corp disclose the individual responsible for D&I?
Does Medipal Holdings Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Medipal Holdings Corp disclose current and / or historical scope 2 emissions?
Does Medipal Holdings Corp disclose water use targets?
Does Medipal Holdings Corp have careers partnerships with academic institutions?
Did Medipal Holdings Corp have a product recall in the last two years?
Does Medipal Holdings Corp disclose incidents of discrimination?
Does Medipal Holdings Corp allow for Work Councils/Collective Agreements to be formed?
Has Medipal Holdings Corp issued a profit warning in the past 24 months?
Does Medipal Holdings Corp disclose parental leave metrics?
Does Medipal Holdings Corp disclose climate scenario or pathway analysis?
Does Medipal Holdings Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Medipal Holdings Corp disclose the pay ratio of women to men?
Does Medipal Holdings Corp support suppliers with sustainability related research and development?
Does Medipal Holdings Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Medipal Holdings Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Medipal Holdings Corp involved in embryonic stem cell research?
Does Medipal Holdings Corp disclose GHG and Air Emissions intensity?
Does Medipal Holdings Corp disclose its waste policy?
Does Medipal Holdings Corp report according to TCFD requirements?
Does Medipal Holdings Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Medipal Holdings Corp disclose energy use targets?
Does Medipal Holdings Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Medipal Holdings Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Medipal Holdings Corp
These potential risks are based on the size, segment and geographies of the company.
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.